Literature DB >> 6639160

Glucose turnover and recycling in colorectal carcinoma.

W A Kokal, A McCulloch, P D Wright, I D Johnston.   

Abstract

Glucose metabolism is affected by various pathologic states including tumors. In this project, glucose turnover and recycling rates in 11 patients with colorectal carcinoma were measured using a double-labelled 3-3H and 1-14C glucose injection technique. Fasting blood glucose, lactate, pyruvate, alanine, glycerol, 3-hydroxybutyrate, acetoacetate, plasma cortisol, and plasma insulin concentrations were also measured. No patient in the study had a history of diabetes mellitus or endocrine disorders, nor any abnormal liver function tests. The findings demonstrated a significantly elevated glucose turnover rate in patients with Dukes C and D lesions in comparison to patients with Dukes B lesions. Cori recycling rates were not significantly different between Dukes B vs. Dukes C and D patients. There were no differences between Dukes B and Dukes C and D patients in any of the metabolites measured. Furthermore, there were no significant differences in glucose turnover or recycling rates as a function of pre-illness weight loss. These data suggest that, when colorectal carcinoma extends beyond the limits of the bowel wall, glucose metabolism is significantly altered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639160      PMCID: PMC1353131          DOI: 10.1097/00000658-198311000-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test.

Authors:  P A MARKS; J S BISHOP
Journal:  J Clin Invest       Date:  1957-02       Impact factor: 14.808

3.  Diabetes mellitus and carbohydrate metabolism in patients with cancer.

Authors:  A S GLICKSMAN; W P L MYERS; R W RAWSON
Journal:  Med Clin North Am       Date:  1956-05       Impact factor: 5.456

4.  Turnover and recycling of glucose in man during prolonged fasting.

Authors:  D A Streja; G Steiner; E B Marliss; M Vranic
Journal:  Metabolism       Date:  1977-10       Impact factor: 8.694

5.  A kinetic spectrophotometric assay for rapid determination of acetoacetate in blood.

Authors:  C P Price; B Llyod; G M Alberti
Journal:  Clin Chem       Date:  1977-10       Impact factor: 8.327

6.  Lactate metabolism in patients with cancer.

Authors:  C Waterhouse
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

7.  Gluconeogenesis from alanine in patients with progressive malignant disease.

Authors:  C Waterhouse; N Jeanpretre; J Keilson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

8.  METABOLISM OF NEOPLASTIC TISSUE. XVII. BLOOD GLUCOSE REPLACEMENT RATES IN HUMAN CANCER PATIENTS.

Authors:  G A REICHARD; N F MOURY; N J HOCHELLA; R C PUTNAM; S WEINHOUSE
Journal:  Cancer Res       Date:  1964-01       Impact factor: 12.701

9.  Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients.

Authors:  K Lundholm; S Edström; I Karlberg; L Ekman; T Scherstén
Journal:  Cancer       Date:  1982-09-15       Impact factor: 6.860

10.  Metabolic alterations in a noncachectic animal tumor system.

Authors:  M E Burt; S F Lowry; C Gorschboth; M F Brennan
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  The effect of tumor bulk on the metabolic response to cancer.

Authors:  J B Koea; J H Shaw
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.